D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$453M |
| 2 |
Oracle
ORCL
|
+$431M |
| 3 |
Apple
AAPL
|
+$376M |
| 4 |
SLB Ltd
SLB
|
+$353M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$746M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
NVIDIA
NVDA
|
+$348M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$307M |
| 5 |
AT&T
T
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 11.63% |
| 3 | Healthcare | 11.01% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
PUT
Regeneron Pharmaceuticals
REGN
$69.9B
| $56.9M | 0.08% |
152,400
-2,700
| -2% | -$988K |
|
302
CALL
Bank of America
BAC
$436B
| $56.9M | 0.08% |
2,307,600
-5,616,400
| -71% | -$152M |
|
303
Restaurant Brands International
QSR
$25.8B
| $56.8M | 0.08% |
1,086,881
-593,867
| -35% | -$33M |
|
304
CALL
Advanced Micro Devices
AMD
$807B
| $56.8M | 0.08% |
3,078,600
-610,600
| -17% | -$13.2M |
|
305
HP
HPQ
$24.3B
| $56.6M | 0.08% |
2,768,822
-1,480,956
| -35% | -$34.5M |
|
306
Telus
TU
$16.2B
| $56.6M | 0.08% |
3,408,842
+1,835,842
| +117% | +$31.9M |
|
307
United Parks & Resorts
PRKS
$2.12B
| $56.5M | 0.08% |
2,556,127
+624,027
| +32% | +$16.7M |
|
|
AGN
308
DELISTED
Allergan plc
AGN
| $56.4M | 0.08% |
422,073
+5,127
| +1% | +$840K |
|
309
Liberty Broadband Class C
LBRDK
$4.44B
| $56.4M | 0.08% |
782,813
+128,310
| +20% | +$10.3M |
|
310
Canadian Pacific Kansas City
CP
$81.1B
| $55.8M | 0.08% |
1,570,895
-468,005
| -23% | -$18.7M |
|
311
Southern Company
SO
$109B
| $55.2M | 0.08% |
1,257,654
+1,053,357
| +516% | +$47.9M |
|
312
PUT
Teva Pharmaceuticals
TEVA
$36.2B
| $55.2M | 0.08% |
3,577,000
-620,000
| -15% | -$12.7M |
|
313
TE Connectivity
TEL
$60.2B
| $55.2M | 0.08% |
729,229
-265,429
| -27% | -$20.4M |
|
314
Vanguard Global ex-US Real Estate ETF
VNQI
$3.5B
| $55.1M | 0.08% |
1,051,595
-496,301
| -32% | -$26.8M |
|
315
Regency Centers
REG
$15.1B
| $54.9M | 0.08% |
935,419
+503,181
| +116% | +$31.5M |
|
316
PUT
Starbucks
SBUX
$118B
| $54.8M | 0.08% |
850,300
+169,700
| +25% | +$10.6M |
|
317
Autohome
ATHM
$2.46B
| $54.5M | 0.08% |
696,800
+165,513
| +31% | +$12.5M |
|
318
Best Buy
BBY
$18.6B
| $54.4M | 0.08% |
1,027,591
+81,817
| +9% | +$5.34M |
|
319
Progressive
PGR
$125B
| $54.2M | 0.07% |
899,013
-1,152,804
| -56% | -$76.7M |
|
320
Caterpillar
CAT
$402B
| $53.7M | 0.07% |
422,942
-134,667
| -24% | -$17.5M |
|
|
ZNGA
321
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $53.5M | 0.07% |
13,619,872
-1,954,860
| -13% | -$7.4M |
|
322
Check Point Software Technologies
CHKP
$13.6B
| $53.5M | 0.07% |
520,786
+498,037
| +2,189% | +$54.7M |
|
323
Bio-Rad Laboratories Class A
BIO
$8.47B
| $53.2M | 0.07% |
229,096
+38,604
| +20% | +$10.4M |
|
324
Post Holdings
POST
$4.14B
| $53M | 0.07% |
908,468
+119,299
| +15% | +$7.19M |
|
325
CALL
Biogen
BIIB
$29.5B
| $52.5M | 0.07% |
174,400
+50,000
| +40% | +$16M |
|
Similar funds
D.E. Shaw & Co's Q4 2018 Portfolio in Review
As of Q4 2018, D.E. Shaw & Co held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
D.E. Shaw & Co deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.
- D.E. Shaw & Co's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
- D.E. Shaw & Co added most to Oracle in Q4 2018, an estimated $431M increase.
- D.E. Shaw & Co's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
- D.E. Shaw & Co fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
- D.E. Shaw & Co's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
- D.E. Shaw & Co opened 541 new positions and closed 497 in Q4 2018.
- D.E. Shaw & Co's portfolio value fell 13% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.